Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids
Status:
Completed
Trial end date:
2020-12-28
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial (RCT) to assess the comparative effectiveness of
Levonorgestrel Intrauterine System (LNG-IUS) to Tranexamic Acid (TA) for the treatment of
heavy menstrual bleeding (HMB) in women with clinically-significant fibroids.
Phase:
Phase 4
Details
Lead Sponsor:
Shannon K. Laughlin-Tommaso
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)